acyclovir

Product NDC
70934-556
11-digit product format
709340556
Labeler code
70934
Product ID
70934-556_f14bb0e9-5cfb-e51b-e053-2995a90ac293
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
acyclovir
Dosage form
TABLET
Route
ORAL
Labeler
Denton Pharma, Inc. DBA Northwind Pharmaceuticals
Application
ANDA077309
Marketing category
ANDA
Marketing start
2020-02-19
Marketing end
2023-01-31
Substance
ACYCLOVIR
Active strength
800 mg/1
Pharmacologic classes
DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
70934-556-35EA - Each70934-55686c7b4cb-72c2-4c9e-83a5-36e6cabf219c12022-11-07

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70934-556-357093405563535 TABLET in 1 BOTTLE, PLASTIC (70934-556-35) 35 tablet2020-02-190000-00-00NoNoCurrent
70934-556-407093405564040 TABLET in 1 BOTTLE, PLASTIC (70934-556-40) 40 tablet2020-03-120000-00-00NoNoCurrent